Germline DDX41 mutant predisposition syndromes: Slow driver states to hematological malignancies

American Journal of Hematology（2023）

引用 0|浏览0

暂无评分

摘要

Mrinal M Patnaik has received research funding from StemLine Pharmaceuticals, Kura Oncology, and Epigenetix. He has served on the advisory board for CTI pharmaceuticals. No original data contained in the manuscript.

查看译文

关键词

mutant predisposition syndromes,hematological malignancies,slow driver states

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要